Next Article in Journal
The Application of Chemometrics in Metabolomic and Lipidomic Analysis Data Presentation for Halal Authentication of Meat Products
Previous Article in Journal
Dimethylammonium Cation-Induced 1D/3D Heterostructure for Efficient and Stable Perovskite Solar Cells
Previous Article in Special Issue
The Intervention of Prebiotics on Depression via the Gut–Brain Axis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 27
Issue 21
10.3390/molecules27217568
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evaluation of Antioxidant Activity and Biotransformation of Opuntia Ficus Fruit: The Effect of In Vitro and Ex Vivo Gut Microbiota Metabolism

by
Ibrahim E. Sallam
1,
Ulrike Rolle-Kampczyk
2,
Stephanie Serena Schäpe
2,
Soumaya S. Zaghloul
1,
Riham S. El-Dine
3,
Ping Shao
4,
Martin von Bergen
2,5,* and
Mohamed A. Farag
3,*
1
Pharmacognosy Department, College of Pharmacy, October University for Modern Sciences and Arts (MSA), 6th of October City, Giza 12566, Egypt
2
Department of Molecular Systems Biology, Helmholtz-Centre for Environmental Research—UFZ GmbH, 04318 Leipzig, Germany
3
Pharmacognosy Department, College of Pharmacy, Cairo University, Cairo 11562, Egypt
4
Department of Food Science and Technology, Zhejiang University of Technology, Hangzhou 310014, China
5
German Centre for Integrative Biodiversity Research, (iDiv) Halle-Jena-Leipzig, Puschstraße 4, 04103 Leipzig, Germany
*
Authors to whom correspondence should be addressed.
Molecules 2022, 27(21), 7568; https://doi.org/10.3390/molecules27217568
Submission received: 28 August 2022 / Revised: 28 October 2022 / Accepted: 1 November 2022 / Published: 4 November 2022
(This article belongs to the Special Issue Interactions between Food Chemistry and Gut Microbiota)
Browse Figures
Review Reports Versions Notes

Abstract

:
Opuntia ficus-indica biological effects are attributed to several bioactive metabolites. However, these actions could be altered in vivo by biotransformation reactions mainly via gut microbiota. This study assessed gut microbiota effect on the biotransformation of O. ficus-indica metabolites both in vitro and ex vivo. Two-time aliquots (0.5 and 24 h) from the in vitro assay were harvested post incubation of O. ficus-indica methanol extract with microbial consortium, while untreated and treated samples with fecal bacterial culture from the ex vivo assay were prepared. Metabolites were analyzed using UHPLC-QTOF-MS, with flavonoid glycosides completely hydrolyzed in vitro at 24 h being converted to two major metabolites, 3-(4-hydroxyphenyl)propanoic acid and phloroglucinol, concurrent with an increase in the gallic acid level. In case of the ex vivo assay, detected flavonoid glycosides in untreated sample were completely absent from treated counterpart with few flavonoid aglycones and 3-(4-hydroxyphenyl)propanoic acid in parallel to an increase in piscidic acid. In both assays, fatty and organic acids were completely hydrolyzed being used as energy units for bacterial growth. Chemometric tools were employed revealing malic and (iso)citric acids as the main discriminating metabolites in vitro showing an increased abundance at 0.5 h, whereas in ex vivo assay, (iso)citric, aconitic and mesaconic acids showed an increase at untreated sample. Piscidic acid was a significant marker for the ex vivo treated sample. DPPH, ORAC and FRAP assays were further employed to determine whether these changes could be associated with changes in antioxidant activity, and all assays showed a decline in antioxidant potential post biotransformation.

1. Introduction

Opuntia ficus is a widely distributed cactus fruit species belonging to the family Cactaceae. Opuntia genus contains more than 1500 species found worldwide mainly in Mexico as well as Australia and the Mediterranean region [1]. Many reported pharmacological activities have been attributed to O. ficus and its plant constituents including antioxidant [2], anticancer [3], antidiabetic [4] and hepatoprotective [5] activities. Although synthetic analogues of plant bioactives are available and they could exhibit the desired biological activity, plant products are acknowledged to be more effective as the desired activity arises from a cumulative effect of all plant metabolites rather than a single compound [6]. Among the reported bioactives in O. ficus include phenolic acids, flavonoids and betalains, to which several studies have attributed the fruit’s biological effects [7,8]. However, in vitro determination of the bioactivity of such metabolites is not sufficient to predict their potential in vivo effects, and this might be attributed to the possible biotransformation that takes place during their interaction with gut microbiota [9]. Therefore, there is an increasing need to establish new approaches to assess not only the biological activity of plant constituents, but also to predict their in vivo effects based on the plant’s chemical composition. Gut microbiota is a large diverse group of microorganisms that live in the gastrointestinal tract, mainly the colon, and their number can reach up to the tens of trillions, which is 10 times higher than the number of human body cells. Bacteria represent the major part of the microbiota with around 1000 species belonging to two main bacterial phyla: Firmicutes and Bacteroidetes [10]. Many reports have indicated that there is a mutual interaction between the gut microbiota and dietary constituents [11,12,13,14,15,16,17]. As bioactive constituents from dietary substances can influence the composition and the metabolism of gut microbiota, gut microbiota can, on the other hand, yield a series of biotransformed metabolites, thus affecting food biological activity either positively or negatively [18]. Most dietary polyphenols are biotransformed by various enzymes from the gut microbiota inside the colon, and this conversion is essential for their absorption and ultimate biological activity. Accordingly, the colon is regarded as a vital site for metabolism rather than being a simple excretion route [17]. Several biotransformation reactions have been attributed to gut bacterial enzymes including demethylation, dehydroxylation, decarboxylation and ring cleavage, as well as hydrolysis of glycosides, amides and esters [19]. Among the most common effects of gut microbiota on dietary constituents is their impact on plant glycosides, and hydrolysis of such glycosides leads to the formation of metabolites that are potentially more absorbable and thus more biologically active, while further bacterial degradation of aglycones leads to the production of either more or less active compounds based on the metabolites formed [17]. Metabolomics is a holistic approach used for the untargeted high-throughput analysis of complex metabolite matrices that are characteristic of plant extracts [19]. Such an approach was driven by the recent advances in hyphenated techniques such as ultra-performance liquid chromatography coupled to tandem mass spectroscopy (UHPLC-QTOF-MS-MS) analysis. The high-throughput analysis of such a technique represents a vital tool to simplify the complex nature of biotransformation reactions and to aid in monitoring structural changes in an untargeted manner [20]. Multivariate data analysis tools, such as principal component analysis (PCA) and orthogonal projection discriminant analysis (OPLS-DA), have been increasingly applied to help in pinpointing metabolites responsible for discriminating biotransformed extracts, and thus giving new insights on novel compounds with potential biological effect [21]. The aim of this research was to investigate the impact of gut microbiota represented by microbial consortium on the metabolism of plant constituents from O. ficus using the UHPLC-QTOF-MS approach in relation to their antioxidant activity aided by chemometric tools.

2. Results

2.1. In Vitro Impact of Gut Culture Represented by Microbial Consortium

UHPLC-QTOF-MS was employed to monitor various chemical classes of O. ficus metabolites for any possible changes attributed to the effect of the selected microbes. We have previously reported the O. ficus metabolome using same UHPLC-QTOF-MS platform [1], and extend herein to report on how the gut microbiota can impact its metabolite composition. Detected O. ficus fruits’ metabolome is composed mostly of 15 fatty acids, 9 flavonoids, 7 phenolics/phenolic acids, and 7 organic acids, in addition to a triterpenoid (Table 1). Upon inoculation of gut microbiota, dramatic changes in metabolite pattern and percentile levels were detected, among which 6 metabolites were detected post incubation indicating their origin as biotransformed metabolites, being absent from the original fruit matrix. Interestingly, no betalains, which is a major class of metabolites in O. ficus, were detected in both the in vitro and ex vivo assays. This might be attributed to nature of the extraction procedure being pure alcoholic rather than hydroalcoholic, which hinders the extraction of these hydrophilic pigments. It was previously reported that betalains best recovery occurs using pure water extraction and the addition of small percentage of ethanol or methanol, which could enhance their extraction [22]. Likewise, a low operating temperature plays a vital role in maintaining the stability of betalains; it was reported that the most adequate extraction conditions for beetroot betalains occurred with an extraction time of 1 h, operating temperature of 20 °C, and solvent ratio of 0.8 w/v of aqueous ethanol, with increased temperature to decreased yield [23]. This also demonstrates that low temperature enhances and preserves the extracted betalains, which was not the case in our research, as O. ficus extract was incubated with bacteria for a period of 24 h at 37 °C, which might have contributed to its degradation. Finally, several studies have reported that betalains’ extraction should be performed in an acidic medium, which is necessary for both the extraction and the preservation of betalains [24], reporting that the optimized conditions for the maximum recovery of betalains were at citric acid of 1.5% and ethanol concentration of 50%. Acidification of the extraction condition might not have favorited the extraction of the other reported classes in O. ficus. Considering that extraction and incubation conditions were not in favor of betalains recovery and/or stability, this explain why no betalains were detected in both assays. A complete list of the identified metabolites with their mass spectral data is presented in Table 1. Chemical structure of major metabolites identified using UHPLC-QTOF-MS is shown in Figure 1.

2.1.1. Flavonoids

Nine flavonoids were detected at 0.5 and 24 h and treated O. ficus within the elution range of tR (400–900 s) (Supplementary Figure S1), consistent with their nature as relatively non-polar metabolites. The first detected flavonol was isorhamnetin glycoside in peak 12 with [M-H]− at m/z 541.2307 (C26H38O12)−, with product ions at m/z 315.13 [M-C9H8O-H]− corresponding to isorhamnetin aglycone [1]. Likewise, peaks 17 and 19 were detected with molecular formulas of (C25H24O15)− and (C15H10O7−) and a common ion at m/z 301.03, annotated as quercetin aglycone and quercetin glycoside, respectively [25]. Glycosides denote that the metabolite gave the characteristic product ion of their corresponding aglycone; however, the sugar part was undetermined unequivocally, which is why they were annotated as glycosides in general and not of a specific sugar. Another flavonol was detected in peak 16 [M-H]− at m/z 285.043 (C15H10O6)−, with product ions at m/z 151.03 [M-C8H6O2-H]− assigned as kaempferol. Naringenin flavanone was detected in peak 20 with [M-H]− at m/z 271.0627 and a molecular formula of (C15H11O5)-, with product ions at m/z 151.01 [M-C8H8O-H]− and m/z 119.04 [M-C7H4O4-H]−. Another flavonoid subclass is that of flavones, which were detected in peaks 26, 27 and 28 corresponding to apigenin [M-H]− m/z 269.0478 (C15H9O5)−, diosmetin [M-H]− at m/z 299.0577 (C16H12O6)− and acaetin [M-H]− m/z 283.0643 (C16H12O5)− aglycones. Confirmation of aglycone was based on product ions at m/z 151 [M-C8H4O-H]− and m/z 117.03 [M-C7H4O4-H]− in peak 26 versus m/z 284.03 [M-CH3-H]− and m/z 151 [M-C8H6O2-H]− [26] in peak 27 and m/z 151.01 [M-C9H8O-H]− and m/z 117.03 [M-C8H6O4-H]− in peak 28 [27].

Biotransformation of Flavonoids

Almost all bacterial strains employed within the ex vivo assay are reported to code for hydrolytic enzymes, mainly β-glucosidase. These enzymes are reported to be active within few minutes of bacterial incubation with plant extracts viz., Bacteroides thetaiotaomicron [28], Bifidobacterium longum [15], Clostridium genus [29], Escherichia coli [30] and Lactobacillus plantarum [31]. Thus, most of the detected flavonoids were aglycones at both the initial 0.5 h and final 24 h time points, suggesting that they were readily metabolized to their respective aglycone and contrary to the abundance of glycosides in the fruit extract [32]. Interestingly, a differential response among flavonoid glycosides was observed exemplified in the rapid degradation of flavone/flavonones compared to flavonols. Flavonoid aglycones, such as naringenin, diosmetin and acacetin, were only detected at 0.5 h and completely hydrolyzed at 24 h, whereas quercetin and isorhamnetin flavonol glycosides were detected at 0.5 and 24 h, with 0.48- and 0.82-fold decrease in their levels, respectively, at the late time point. The detection of kaempferol aglycone at 24 h and absent from 0.5 h suggests that it is a hydrolytic product from the bacterial metabolism of plant constituents. As a result of these differential responses, the total flavonoid content showed relatively similar percentages between the 0.5 and 24 h samples (Figure 2A, Supplementary Table S1).
Following aglycone cleavage from glycoside, it undergoes extensive metabolism by the colon bacteria to simpler phenolics from A and B rings mediated by the C-ring cleavage (Figure 3). Clostridium [16], Eubacterium [33] and other gut microbiota belonging to the Butyrivibrio genus [34], employed herein, are among the bacterial strains reported to be involved in such cleavage. Subsequent to the C ring cleavage, dehydroxylation occurs with the original hydroxylation of A and B rings found to affect the resulting metabolites. A major metabolite suggested to be derived from the dehydroxylation of the B ring is 3-(4-hydroxyphenyl) propionic acid (Figure 3), detected exclusively at 24 h in peak 15 with [M-H]− m/z 165.0578 (C9H9O3)−, with product ions at m/z 147.04 [M-H2O-H]− and m/z 119.05 [M-H2O-CO-H]− (Supplementary Figure S3E) [16,33]. Likewise, the phloroglucinol A ring cleavage product was detected only at 24 h in peak 7 with [M-H]− m/z 125.0256 (C6H5O3)−, with product ions at m/z 106.14 [M-H2O-2H]− and m/z 91.08 [M-2OH-H]− (Supplementary Figure S3D) [34]. Phloroglucinol is a polyphenolic compound with a broad range of reported biological effects including antioxidant [35], cytotoxic [36] and antidiabetic [37] activities. Moreover, it has been widely used for the treatment of spasmodic pain associated with irritable bowel syndrome and renal colic [38].

2.1.2. Phenolics and Organic Acids

Phenolic and organic acids were the second most abundant classes represented by 14 metabolites. Their abundance is visible within the elution region of tR (50–500 s) (Supplementary Figure S1), being most polar and eluting at a high water eluent composition. Among the detected organic acids were malic acid in peak 1 with [M-H]− at m/z 133.0160 (C4H6O5)−, with product ions at m/z 115 [M-H2O-H]− and m/z 71.01 [M-H2O-COO-H]− (Supplementary Figure S3A), and succinic acid in peak 6 with [M-H]− at m/z 117.0205 (C4H6O4)−, with product ions at m/z 99.01 [M-H2O-H]− and m/z 73.03 [M-COO-H]− [39]. Several peaks were annotated for (iso)citric acid and its derivatives in peak 3 [M-H]− at m/z 191.0222 (C6H7O7)− with product ions at m/z 173.03 [M-H2O-H]− and m/z 129.01 [M-COO-H2O-H]− annotated as (iso)citric acid (Supplementary Figure S3C), and its derivatives in peaks 4, 8 and 13 with similar fragmentation pattern showing product ions at m/z 191.05 [M-R-H]− and m/z 127 [M-R-COO-H2O-H]− ascribed for the presence of (iso)citric acid moiety and annotated as hydroxy and homocitric acid and dimethyl citrate, respectively [40]. Finally, peak 10 was assigned as fumarylacetoacetic acid [M-H]− at m/z 199.0265 (C8H7O4)− with a product ion at m/z 101.38 ascribed for the loss of fumaric acid [21]. Alternatively, gallic acid was detected in peak 2 [M-H]− at m/z 169.0158, with product ions at m/z 125.02 [M-COO-H]− and m/z 107.01 [M-COO-H2O-H]− (Supplementary Figure S3B). Other gallic acid derivatives were detected in peaks 14 and 18 with product ions at m/z 169.01 [M-R-H]−, m/z 125.02 [M-R-COO-H]− and m/z 107.01 [M-R-COO-H2O-H]− ascribed for gallic acid moiety being assigned as methyl gallate and ethyl gallate esters, respectively [41].

Biotransformation of Phenolics and Organic Acids

Phenolics showed a 2.5-fold increase, while total organic acids showed an 0.82-fold decrease post incubation (Figure 2A, Supplementary Table S1). The most pronounced decrease in organic acids was observed in case of malic and (iso)citric acids and its derivatives by 0.2- and 0.8-fold, respectively. These organic acids are likely utilized within the glyoxylate pathway (Figure 4) for metabolic energy production necessary for bacterial growth in culture [42]. In contrast, succinic acid, a structural analogue to malic acid, showed an opposite pattern being found at increased levels at 24 h (ca. 1.72-fold), which is likely attributed to the highly reported microbial production of succinic acid from (iso)citric acid through isocitrate lyase as a major fermentation product [43]. Fumarlyacetoacetic acid (maleylacetoacetic acid) showed a similar accumulation pattern (ca. 3.8-fold increase), which is attributed to being an intermediate product in the metabolism of the tyrosine amino acid mainly by fumarylacetoacetate hydrolase, which is necessary for its use as a substrate in energy production [44].
With regards to gallic acid derivatives showing more abundance at 0.5 h versus gallic acid detected at higher levels at 24 h (1.5-fold increase), this indicates the hydrolysis of these derivatives via esterase (tannase) and or decarboxylase enzymes. Another hydrolytic product of phenolics detected in culture was pyrogallol found exclusively at 24 h as a possible hydrolytic product of gallic acid decarboxylation. Lactobacillus plantarum included in the culture consortium is the only reported bacterial species to encompass esterase (tannase) and decarboxylase enzymes [12], which are essential for the bacterial hydrolysis of gallotannins abundant in O. ficus [45]. Gallic acids and their decarboxylated metabolite pyrogallol exhibit several pharmacological effects including antioxidant [46], antimicrobial [47] and anticancer [14] activities.

2.1.3. Fatty Acids

Fatty acids were the most abundant metabolite class in extract represented by 15 peaks as evident from the total ion chromatogram within the elution range of tR (750–1450 s) (Supplementary Figure S1). The late elution is consistent with the non-polar nature of these metabolites to include linoleic and oleic acids detected in peaks 37 and 39 with [M-H]− at m/z 279.2351 and 281.2521 and a molecular formula of (C18H31O2)−and (C18H33O2)−, respectively. Two mono-hydroxylated fatty acids were detected in peaks 32 and 34 showing loss of water molecule (-18 amu) and annotated as hydroxylinoleic acid and hydroxypalmitic acid, respectively; likewise, palmitoleic acid and palmitic acid were detected in peaks 36 and 38, respectively [48,49]. Peak 23 with [M-H]− at m/z 329.2358 (C18H32O5)− with product ions at m/z 155.03 [M-C7H10O5-H]− and m/z 133.01 [M-C14H28-H]− presented a typical fragmentation pattern of tri-hydroxyoctadecenoic acid [20]. Another dihydroxy fatty acid was detected in peak 21 [M-H]− at m/z 287.2249 (C16H31O4)− with product ions at m/z 271.02 [M-O-H]− and m/z 243.05 [M- COO-H]− assigned as dihydroxyhexadecanoic acid. A similar fragmentation pattern was observed in peaks 22, 24 and 25, assigned as tri- and dihydroxy fatty acid derivatives.

Biotransformation of Fatty Acids

Upon bacterial inoculation, fatty acids showed a decline of 0.6-fold (Figure 2A, Supplementary Table S1), as almost all detected fatty acids were depleted at 24 h, which is attributed to the fact that all employed bacterial strains within this assay are reported to metabolize long-chain fatty acids (LCFAs) to short-chain fatty acids (SCFAs) i.e., acetate, propionate, butyrate and valerate (Figure 4). This was evident by the post incubation 1.75-fold increase of valerate SCFA observed in peak 11 as hydroxyvaleric acid with [M-H]− at m/z 117.0566 and a molecular formula of C5H9O3− [50]. Valerate is exclusively produced by bacterial fermentation of amino acids and polypeptides, as well as fatty acids produced by several bacterial species including Clostridium, which is used in this assay [51]. Therefore, gut microbiota composition affects the production of SCFAs, which have been linked to improving the gut health through a number of local effects, ranging from maintaining intestinal barrier integrity, mucus production and protection against inflammation to reduction of the risk of colorectal cancer [52]. Fatty acids are considered a major energy source, whereas their derivatives regulate several cellular responses essential for bacterial growth [13]. Fatty acids along with carbohydrates metabolism are mediated anaerobically via the glyoxylate pathway that leads to the formation of SCFAs (Figure 4) [43].

2.2. Impact of Gut Culture Represented by Actual Fecal Matter in Ex Vivo Assay

To better assess of gut microbiota on O. ficus fruit metabolites, methanol extract of O. ficus was incubated with an ex vivo culture of the human gut microbiome isolated from fecal matter of a healthy donor as mentioned under Experimental Section 2.4. The longer incubation time of 48 h, as well as utilizing actual fecal matter as a source for gut microbiota, yielded better insight on the possible biotransformation reactions that occur within the human body and helped confirm results derived from in vitro gut culture assay (Figure 2A). The same UHPLC-QTOF-MS-MS platform was employed to detect metabolite changes between the untreated and treated O. ficus extract. A representative chromatogram of O. ficus untreated and treated samples is depicted in Supplementary Figure S2. Similar metabolite classes as the in vitro assay were detected, including 14 phenolic and organic acids, 9 flavonoids and 10 fatty acids. Likewise, dramatic changes were observed in metabolites, including 6 peaks detected post incubation in the treated sample, indicating their origin as biotransformed metabolites rather than being originally present within O. ficus matrix. A complete list of the identified metabolites with their mass spectral data is presented in Supplementary Table S2.

2.2.1. Biotransformation of Flavonoids

In contrast to the 0.5 h sample employed in the in vitro assay, all detected flavonoids in the untreated fruit extract in case of the ex vivo culture were glycosides, confirming the abundance of flavonoids as glycosides within the native plant matrix (Supplementary Table S2), as well as rapid hydrolytic effect of bacterial glucosidase enzymes in the case of the in vitro culture. Upon incubation, all flavonoid glycosides, in spite of their classes, were completely hydrolyzed at 48 h, at which point only their respective aglycones are a product of bacterial metabolism (Supplementary Table S2). Accordingly, the total flavonoids percentage remained relatively the same within the untreated and treated samples (Figure 2B). As in the in vitro assay, 3-(4-hydroxyphenyl) propanoic acid was also detected exclusively at 48 h in the treated sample in peak 17 as a possible hydrolytic product of flavonoid aglycone cleavage imparted by bacterial metabolism (Figure 3).

2.2.2. Phenolic and Organic Acids

In the ex vivo incubation assay, phenolic and organic acids were the most abundant class with 15 metabolites. Their abundance is visible within the total ion chromatogram at the elution region of tR (50–530 s) (Supplementary Figure S2), consistent with their high polarity. Organic acids other than those detected within the in vitro assay were detected including gluconic acid in peak 1 with [M-H]− at m/z 195.0504 (C6H11O7)−, with product ions at m/z 177.01 [M-H2O-H]− and m/z 133.03 [M -COO-H]− [1]. Peak 8 was detected with [M-H]− at m/z 173.0091 (C6H5O6)− with product ions at m/z 129.02 [M-COO-H] and m/z 111.01 [M-H2O-COO-H]−, which is a typical fragmentation pattern of aconitic acid (Supplementary Figure S3F). Mesaconic acid was detected in peak 9 with [M-H]− at m/z 129.0216 (C5H5O4)− with product ion at m/z 85.05 [M-COO-H]− (Supplementary Figure S3G) [53]. Likewise, phenolic acids including caffeoylquinic acid were detected in peak 2 with [M-H]− at m/z 353.0862 with a molecular formula of C16H17O9−, with product ions at m/z 191.01 [M-179-H]− [54]. Cinnamic acid was detected in peak 10 with [M-H]− at m/z 147.0454 (C9H7O2)−, with product ions at m/z 129.01 [M-H2O-H]− and m/z 85.01 [M-H2O-COO-H]−. Another phenolic acid was detected in peak 11 with [M-H]− at m/z 255.0557 with a molecular formula of C11H11O7−, with product ions at m/z 165.05 [M-C2H2O3-OH-H]−, m/z 119.05 [M-C2H2O3-OH-CH2-H]− and 107.05 [M-C4H4O3-H]−, and it was annotated as piscidic acid (Supplementary Figure S3H) [55]. Galloylhexose was detected in peak 14 with [M-H]− at m/z 331.0681 with a molecular formula of C13H15O10−, with product ions at m/z 169.01 [M-C6H10O5-H]− ascribed for the loss of glucose moiety. A few metabolites in peaks 18, 21 and 25 showed a similar fragmentation pattern with product ions at m/z 331.06 [M-R-H]− and 169.03 [M-R-C6H10O5−H]−, suggesting that these metabolites are galloylhexose derivatives [56].

Biotransformation of Phenolic and Organic Acids

Upon incubation, organic acids showed a similar biotransformation behavior to the in vitro assay with a 0.58-fold decrease in treated sample compared with increase in phenolic acids at 4-fold when compared to the untreated sample at 48 h (Figure 2B, Supplementary Table S3). Almost all organic acids were completely depleted upon incubation, except for succinic acid detected at 48 h, confirming its origin as a bacterial metabolite [43]. This can also be attributed to organic acids’ utilization in the aforementioned glyoxylate pathway for energy production with subsequent production of succinic acid through isocitrate lyase as a major fermentation product [42,43]. As for phenolic acids, the most pronounced increase was observed in case of piscidic acid, showing a 12-fold increase at 48 h, which is likely attributed to the release of piscidic acid and other polyphenols from their partial binding to the dietary fibers present in O. ficus under the impact of bacterial enzymes [57]. The detection of gallic acid only at 48 h indicates its absence from the original plant matrix, whereas its detection within the 0.5 h sample in the in vitro assay indicates that, like flavonoids, the 0.5 h treatment was sufficient to release gallic acid from its derivatives (esters). This can be further confirmed by the detection of galloylhexose and its derivatives in the untreated sample of the ex vivo assay (Supplementary Table S2) with no evidence for their presence in the 0.5 h sample of the in vitro assay (Table 1). These galloylhexose derivatives [58] were completely depleted upon incubation, indicating their usage as substrates for bacterial growth. Likewise, caffeoylquinic acid was depleted with incubation, while cinnamic acid showed a 0.3-fold decrease.

2.2.3. Fatty Acids

Next to organic and phenolic acids, fatty acids were the second most abundant class with 10 metabolites visible within the elution range of tR (710–1370 s) (Supplementary Figure S2), which is consistent with their non-polar nature. All of these metabolites were those detected in the in vitro assay except for a fatty acid, which was detected in peak 29 with [M-H]− at m/z 235.1736 and a molecular formula of (C15H24O2)−, with a product ion at m/z 217.17 ascribed for the loss of water molecule (−18 amu) and annotated as trimethyldodecatrienoic acid (farnesoic acid) [59].

Biotransformation of Fatty Acids

As in the in vitro assay, total fatty acids showed a decline of 0.6-fold (Figure 2B, Supplementary Table S2) as almost all fatty acids were depleted upon treatment at 48 h due to the reported bacterial metabolism of LCFAs to SCFAs. This was evident from the detection of propionic acid in peak 3 with [M-H]− at m/z 73.0311 and (C3H5O2)− exclusively at 48 h, as well as the post incubation 8-fold increase of the previously described hydroxyvaleric acid in peak 12. Propionate SCFA is mainly produced by Bacteroidetes phyla through fermentation of carbohydrates as well as organic, fatty and amino acids [60], and to possess an antimicrobial activity against the colonization of the GIT with pathogenic bacteria, such as Salmonella typhimurium, through inhibiting their invasion genes that are essential for penetrating the intestinal epithelium [61]. Additionally, propionic acid intake has been reported to exert a beneficial effect on insulin sensitivity modulated by it inhibitory effect on free fatty acids’ metabolism as well as inflammation associated with insulin resistance [62].

2.3. Multivariate Data Analysis of Fermented O. ficus Extracts Using In Vitro and Ex Vivo Cultures

Multivariate data analysis of the UHPLC-QTOF-MS of the two time points, 0.5 and 48 h, was used to determine metabolic markers for microbial fermentation in an untargeted manner. The UHPLC-QTOF-MS peak abundance-extracted dataset of the in vitro and ex vivo assays were both subjected to unsupervised PCA and supervised OPLS modelling to identify biomarkers for each time point.

2.3.1. Multivariate Data Analysis of MS Dataset of O. ficus in Response to In Vitro Gut Bacterial Culture

The unsupervised data analysis (PCA) failed to provide clear segregation between the two time aliquots in response to the treatment; thus, supervised orthogonal partial least squares discriminant analysis (OPLS-DA) was further employed as supervised model by pooling samples at 0.5 h in one class group versus 24 h in another class group (Figure 5A). Model validation was based on estimating the total variance (R2 = 0.97), prediction goodness parameter (Q2 = 0.92) and p-value for statistical significance. The OPLS model showed clear samples’ segregation with high repeatability, prediction and significantly low regression p-values that are suggestive of no model overfitting. The S-loading plot was further investigated to visualize both the covariance and the correlation structure between the X-variables and the predictive score (1) of the model. Whereas metabolites with negative p(1) values indicate higher abundance at 0.5 h and a decrease upon incubation, positive p(1) values indicate an increase upon incubation. (Iso)citric as well as malic acid were the only significant model markers for the 0.5 h time point harvest with negative p(1) on S-plot (Figure 5B), likely due to their incorporation and consumption within the glyoxylate pathway needed for energy production. In contrast, no significant markers could be assigned for the 24 h time point.

2.3.2. Multivariate Data Analysis of MS Dataset of O. ficus in Response to Ex Vivo Fecal Bacterial Culture

As in the in vitro assay, PCA failed to provide clear segregation between the untreated and treated samples; thus, OPLS-DA was further employed by pooling the untreated samples in one class group versus treated samples in another class group (Supplementary Figure S4). Model validation was based on estimating the total variance (R2 = 0.99) and the prediction goodness parameter (Q2 = 0.92). The OPLS model showed samples segregation, and (iso)citric, aconitic and mesaconic acids were the only significant model markers for the untreated sample (positive p(1) values). In contrast, piscidic acid was a significant marker for the treated sample at 48 h (negative p(1) value), which might be attributed to polyphenols’ release from their partial binding to O. ficus dietary fibers under the impact of bacterial enzymes.

2.4. Antioxidant Effect of Inoculated O. ficus Samples

Free radicals play an important role in the progression of oxidative stress and many other associated diseases, i.e., cancer and cardiovascular disorders [63]. Thus, there is an increasing interest in not only developing new antioxidant principles especially from plant origin, but also in determining their fate and metabolism inside the body. To assess whether bacterial inoculation and gut culture-mediated biotransformation influence the O. ficus antioxidant effect, we determined extract effects for cultures harvested at 0.5 and 24 h in vitro using 2,2-Diphenyl-1-Picrylhydrazyl (DPPH), Ferric-Reducing Antioxidant Power (FRAP) and Oxygen Radical Absorbance Capacity (ORAC) assays. The 0.5 h time point showed higher antioxidant activity in both ORAC and FRAP assays (137.5 and 22.3 µM TE/mg extract, respectively), compared to 24 h aliquot (40.8 and 7.9 µM TE/mg extract, respectively). Likewise, in the DPPH assay, the two time aliquots (0.5 and 24 h) in the in vitro assay showed slightly higher IC50 values of 191.2 µg/mL at 24 h compared to 174.1 µg/mL at 0.5 h and compared to that of the standard trolox (24.42 µg/mL). The higher antioxidant capacity demonstrated by original fruit extract subjected to less microbial degradation (0.5 h aliquot) suggests that the microbial degradation and metabolites’ biotransformation exhibited in the 24 h aliquot negatively influence its antioxidant activity. Whether the decline in other effects attributed to O. ficus follow the same pattern should be examined.

3. Materials and Methods

3.1. Plant Material

Fresh samples from red ‘Rose’ cultivar of O. ficus were harvested when fully mature ranging in size from 4 to 9 cm (length) and 3 to 5 cm (diameter). Fruits were peeled using a razor blade and were lyophilized as whole parts using a Stellar® Laboratory Freeze Dryer (Millrock, Inc., New York, NY, USA), stored at −20 °C and extracted after grinding within 1–2 wk for metabolite analysis. Methanol extract was prepared from peeled O. ficus ‘Rose’ FI fruit powder by cold maceration over 48 h using 100% methanol until exhaustion. Extract was then filtered, and the supernatant was subjected to evaporation under vacuum at 40 °C until complete dryness. Extracts were placed in tight glass vials and stored at −20 °C until further analysis.

3.2. Gut Microbiota Culture

The microorganism consortium used in this study is a model for the intestinal microbiota and described as the extended simplified intestinal human microbiota—SIHUMIx. Microorganisms were selected according to their occurrence in humans, the spectrum of fermentation products formed and the ability to form a stable community by [64]. Co-cultured bacterial species included Anaerostipes caccae (DSMZ 14662), Bacteroides thetaiotaomicron (DSMZ 2079), Bifidobacterium longum (NCC 2705), Blautia producta (DSMZ 2950), Clostridium butyricum (DSMZ 10702), Clostridium ramosum (DSMZ 1402), Escherichia coli K-12 (MG1655) and Lactobacillus plantarum (DSMZ 20174), all cultivated as single and provided by the Helmholtz-Centre for Environmental Research-UFZ, Leipzig, Germany. Culturing of bacteria was previously described in [19]. Briefly, all bacteria were cultivated in brain–heart infusion (BHI) medium (Roth®, Karlsruhe, Germany) under anaerobic conditions at 37 °C and 175 rpm and shaken for 72 h prior to inoculation. All strains were shown to be able to grow equally in the medium. The BHI medium was prepared by mixing 37 g of brain–heart infusion, 0.5 g of L-cysteine hydrochloride (Biochemica®, Ulm, Germany), 0.001 g of resazurin (MP biomedicals, Irvine, CA, USA), 10 mL of Vitamin K hemin solution (Becton Dickinson, Sandy, UT, USA) and 5 g of yeast extract (Chemsolute, Renningen, Germany) in 1 L of sterile water. Gut bacteria cultured in the brain–heart infusion medium (optical density of 0.1, measured at 600 nm) was left to grow under anaerobic condition at 37 °C for 18 h until the optical density reached 1.7 prior to O. ficus extract addition. Each culture was performed in triplicate to assess for biological replicates for each treatment, in addition to 3 blank cultures made of SIHUMI and BHI medium without treatment.

3.3. In Vitro Incubation of Plant Extract with Gut Bacterial Culture

Stock solution of O. ficus was prepared at an initial concentration of 50 mg/mL in 50:50 methanol: growth media. First, a 1 mL aliquot of the stock solution was incubated in 10 mL of growth media containing selected microbes from the gut microbiota to achieve a final concentration of 5 mg/mL. Finally, 3 to 4 mL of the prepared samples were harvested at two time intervals, 0.5 and 24 h, for analysis to represent the initial time point, at which no biotransformation reactions are expected to have occurred, and the final time point, at which all biotransformation reactions would have occurred by then microbiota-treated functional food assays, respectively. This method was previously reported by our group to assess the mutual impact between gut microbiota and seven functional foods regarding their primary metabolites [19]. Blank cultures were prepared by adding an equivalent amount of 50 and 500 µL 100% methanol into the culture medium, kept under the same condition and compared to the culture receiving no solvent treatment. All harvested aliquots as well as blanks were subjected to UHPLC-QTOF-MS-MS analysis to monitor the chemical changes of different classes of plant metabolites attributed to the selected gut microbes. All analyses were done from three independent triplicate cultures.

3.4. Ex Vivo Incubation of Plant Extract with Gut Culture from Donor Fecal Sample

Human subject fecal sample was cultured at Princeton University Department of Molecular Biology and provided in this experiment. The exact experimental details of fecal sample collection from the pilot donor (PD), storage, ex vivo culture and xenobiotic incubation were recently described in [65]. All ex vivo cultures in this study were done with PD in mGAM medium (HyServe®, Uffing, Germany) under anaerobic conditions in a water bath at 85 °C using CO2 stream. Resazurin dye (1 g/L) was used as an anaerobic indicator, and 1 mL of sodium sulfide (Sigma-Aldrich, Taufkirchen, Germany) solution (240 g/L) was added to 1 L of anaerobic medium to originally change the resazurin color to yellow (reduced form); samples that turned pink during incubation were discarded for oxygen infiltration. Then, 10 mg of O. ficus extract was incubated with 1 mL mGAM containing the ex vivo culture in an anaerobic jar containing AnaeroPack® (Mitsubishi Gas Chemical America, Inc., New York, N.Y.) and then incubated in a shaking incubator at 37 °C for 48 h. Another 10 mg of the plant extract was prepared under the same conditions and incubated for the same period without the ex vivo culture to represent the untreated plant extract. All analyses were done from three independent triplicate cultures.

3.5. Metabolites Extraction and UHPLC-QTOF-MS-MS Analysis

First, 200 µL of harvested cultures from both in vitro and ex vivo assays was spiked with umbelliferone (Sigma-Aldrich, Taufkirchen, Germany) standard solution dissolved in sterile water to reach a final concentration of 10 µg/mL followed by the addition of 800 µL acetonitrile/methanol mixture (1:1) with incubation at 4 °C for 30 min until complete protein precipitation. The mixture was then centrifuged at 12,000 g using Eppendorf centrifuge for 4 min, with 100 µL of the supernatant then aliquoted and subjected to high-resolution UHPLC-QTOF-MS-MS analysis. For LC-MS/MS measurement, 10 µL of each extract was injected onto a HPLC system coupled online with a 6540 UHD Accurate-Mass Q-TOF (Agilent Technologies). Separation was achieved on a Waters Acquity UPLC® CSH C18 column (2.1 × 100mm, 1.7µm) equipped with a Waters Acquity UPLC® CSH C18 pre-column (2.1 × 50mm, 1.7µm). The autosampler was kept at 5 °C and the column oven was set to 45 °C. Metabolites were separated using a binary solvent system (A: 0.1% FA in water and B: 0.1% FA in ACN) running with the following gradient: 0–5 min: 5% B; 5–19 min: 5–95% B; 19–21 min: 100% B; 21–21.5: 100–5% B; and 21.5–24 min: 5% B. Metabolites were eluted at a constant flow rate of 0.3 mL/min. QTOF was operated in centroid mode and full-scan data were generated with a scan range of 60–1600m/z in positive and negative ionization mode. Out of the survey scan, the 5 most abundant precursor ions with charge state = 1 were subjected to fragmentation. The dynamic exclusion time after two acquired spectra was set to 30 s. The used chromatographic conditions have been successfully used for profiling similar plant matrices [66,67,68].

3.6. UHPLC-QTOF-MS-MS Multivariate Data Analyses

MS peak abundance of metabolites were extracted using MS-DIAL version 4.6 (RIKEN, Yokohama, Japan) as previously described in [69]. The aligned peak abundance data table was further exported to principal component analysis (PCA) and orthogonal projection least squares discriminant analysis (OPLS-DA) using SIMCA-P version 14.1 software package (Umetrics, Umeå, Sweden). All variables were mean-centered and scaled to Pareto variance (Par).

3.7. Antioxidant Assays of Inocculated O. Ficus Samples

3.7.1. DPPH Antioxidant Assay

The antioxidant capacity was determined by the scavenging DPPH radical (Cayman Chemical, Ann Arbor, MI, USA) as described in [1]. Each time aliquot (50 µL) was mixed with 2 mL of 0.09 mM DPPH solution using a shaker at 25 °C and 1000 rpm, followed by incubation at room temperature for 15 min in the dark. Absorbance was measured at 517 nm using a Beckman Coulter DTX 880 microplate reader (Biodirect Corp., Taunton, MA, USA). Trolox (Sigma-Aldrich, Taufkirchen, Germany) was used as a positive control initially prepared as a stock solution of 100 µM in methanol, from which 7 serial dilutions were prepared including 5, 10, 15, 20, 30, 40 and 50 µM. Blank samples were prepared by replacing the time aliquot with 100% methanol. Triplicates were done for each measurement prepared from a different specimen using the same conditions, and the results are expressed as IC50.

3.7.2. FRAP Antioxidant Assay

The ferric-reducing ability assay was carried out according to the method of [70] with slight modifications to be carried out in microplates. Briefly, a freshly prepared tripyridyltriazine (TPTZ) reagent (Sigma-Aldrich, Taufkirchen, Germany) (300 mM Acetate Buffer (PH = 3.6), 10 mM TPTZ in 40mM HCl and 20 mM FeCl3, in a ratio of 10:1:1 v/v/v, respectively) was used. First, 190 µL of the freshly prepared TPTZ reagent were mixed with 10 µL of the sample in 96-well plates (n = 3), and the reaction was incubated at room temperature for 30 min in the dark. At the end of incubation time, the resulting blue color was measured at 593 nm. Trolox stock solution of 2 mM in methanol was prepared, and 8 serial dilutions were prepared in the concentrations of 50, 100, 200, 400, 600, 800, 1000 and 1500 µM. Data are represented as means ± SD. The ferric-reducing ability of the samples is presented as µM trolox equivalent (TE)/mg sample using the linear regression equation extracted from the linear dose–response curve of Trolox.

3.7.3. ORAC Antioxidant Assay

The assay was carried out according to the method of [71], with minor modifications; briefly, 12.5 µL of the prepared samples were incubated with 75 µL fluoresceine (Sigma-Aldrich, Taufkirchen, Germany) (10 nM) for 30 min at 37 °C. Fluorescence measurement (485 EX, 520 EM, nm) was carried out for three cycles (cycle time, 90 sec.) for background measurement. Afterward, 12.5 µL of freshly prepared 2,2-azobis(2-amidinopropane (AAPH) (Sigma-Aldrich, Taufkirchen, Germany) (240 mM) were added immediately to each well. Fluorescence measurement (485 EX, 520 EM nm) was continued for 2.5 h (100 cycles, each 90 s). Trolox stock solution of 1mM in methanol was prepared, and 9 serial dilutions were prepared in the concentrations of 400, 300, 200, 150, 100, 75, 50, 25 and 12.5 µM. Data are represented as means (n = 3) ± SD, and the antioxidant effect of the compound/extract was calculated as µM Trolox equivalents by substitution in the linear regression equation.
Figure 6 illustrates a schematic diagram of the experimental workflow used in this assay.

4. Conclusions

O. ficus is a widespread functional food with many reported biological activities attributed mostly for its fruit’s richness in phenolics. Biotransformation of O. ficus bioactive metabolites is a critical detrimental factor of their absorption, and thus their pharmacological effects, especially in the colon where they are produced. Our results demonstrate the biotransformation pathway adopted by the gut microbiota for the metabolism of flavonoid glycosides in O. ficus fruits through rapid release of their respective aglycones, which are considered more readily absorbable, and hence, more biologically active [72]. Nevertheless, further bacterial degradation of flavonoid aglycones leads to the generation of other derivatives such as phloroglucinol. Polyphenolics, which like flavonoids are considered rich metabolites of O. ficus fruit, were found to be metabolized through the formation of simpler phenolic compounds, i.e., gallic acid and piscidic acids as well as pyrogallol. It should be noted that the current study did not assess the effect of gut microbiota on betalains’ metabolism considering their presence at trace levels in the 100% alcohol extract prepared from the fruits. Future studies can target this class by extracting fruits using polar hydroalcoholic or aqueous solvents. This study showed the bacterial utilization of fatty and organic acids for the production of metabolic energy through glyoxylate pathway evident from their decrease post incubation. Bacterial metabolism of fatty acids was shown to be mediated via the production of SCFAs, presenting an added value considering their role in many metabolic and inflammatory diseases. Moreover, both the in vitro and ex vivo assays showed the same biotransformation effect regarding metabolite classes, i.e., flavonoids, fatty acids and organic acids, with the main mentioned differences being a factor of time. As in the ex vivo assay, we incubated the completely untreated vs treated plant sample for 48 h, while in the in vitro assay, we used 0.5 h vs 24 h aliquots. This demonstrates that the incubation time of gut microbiota with plant metabolites is the main detrimental factor affecting their bioavailability and bioaccessibility. Furthermore, an in vivo approach through human ingestion of plant or food products followed by collection of fecal samples for chemical analysis will not only give more insights on the effect of gut microbiota on plant constituents, but would also give better understanding of the gastrointestinal tract effect as a whole. Likewise, this study demonstrated the impact of gut microbiota on O. ficus antioxidant activity to suggest that biotransformation lessens antioxidant activity according to the DPPH, FRAP and ORAC assays. Determination of other biological effects using isolated biotransformed compounds of bacterial origin should now be conclusive about their importance on the antioxidant activity as well as on others. It should be noted that the adopted metabolites’ extraction conditions and further incubation assay were not in favor of recovering betalains, a pigment in Opuntia fruits. Betalains are polar pigments that need an aqueous solvent for their recovery at acidic conditions [22,24]. Future work should now investigate the impact of gut microbiota on this class specifically, by optimizing the extraction conditions and incubation and/or from other matrices in which betalains are more abundant, as in the case of beet root.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules27217568/s1, Figure S1: Representative UHPLC-QTOF-MS chromatogram for the negative ionization mode of O. ficus methanolic extract incubated with the selected microbial strains at a concentration of 5 mg/ml after 0.5 h (black) and 24 h (red), both chromatograms are characterized by three regions; (50–500) s for phenolic and organic acids, (400–900 s) for flavonoids, and (750–1450 s) for fatty acids; Figure S2: Representative UHPLC-QTOF-MS chromatogram for the negative ionization mode of untreated O. ficus methanolic extract (green) and treated ex-vivo (blue) with bacterial culture isolated from actual fecal matter at a concentration of 10 mg/ml, both chromatograms are characterized by three regions; (50–530 s for phenolic and organic acids, (400–1000 s) for flavonoids, and (710–1370 s) for fatty acids; Figure S3: Tandem mass spectral data of some of the major metabolites studied in in vitro and ex vivo assays namely; (A) Malic acid, (B) Gallic acid, (C) (iso)Citric acid, (D) Phloroglucinol, (E) 3-(4-Hydroxyphenyl) propanoic acid, (F) Aconitic acid, (G) Mesaconic acid, (H) Piscidic acid; Figure S4: (A) OPLS model of O. ficus treated ex-vivo with gut microbiota culture isolated form fecal matter based on treatment; untreated samples (yellow) modeled against treated (red) (B) S-plot of OPLS model, metabolites with positive p(1) values indicates higher abundance in untreated sample mainly; (iso)citric, aconitic and mesaconic acids, while negative p(1) indicates higher abundance within treated sample mainly; piscidic acid; Table S1: Metabolites identified in O. ficus samples treated with gut microbiota at two time intervals; 0.5 and 24 h along with their relative abundance. Results are expressed as relative percentile (average ± std deviation, n = 3) of the total peak areas of identified metabolites; Table S2: Metabolites identified in O. ficus samples; untreated and treated with ex vivo culture of the human gut microbiome isolated from fecal matter along with their relative abundance; Table S3: Metabolites identified in O. ficus untreated and treated ex-vivo with actual fecal matter samples along with their relative abundance. Results are expressed as relative percentile (average ± std deviation, n = 3) of the total peak areas of identified metabolites.

Author Contributions

Conceptualization, M.v.B. and M.A.F.; methodology, M.A.F.; software, I.E.S., U.R.-K. and S.S.S.; validation, I.E.S. and M.A.F.; formal analysis, I.E.S.; resources, M.v.B. and M.A.F.; data curation, I.E.S., U.R.-K., S.S.S. and P.S.; writing—original draft preparation, I.E.S.; writing—review and editing, R.S.E.-D. and M.A.F.; visualization, M.A.F.; supervision, S.S.Z., R.S.E.-D., M.v.B. and M.A.F.; funding acquisition, M.v.B. and U.R.-K. All authors have read and agreed to the published version of the manuscript.

Funding

M.v.B and U.R.K are grateful for the funding by the Novo Nordisk Foundation grant (NNF21OC0066551). M.v.B and U.R.K are thankful for funding of the UFZ for the ProMetheus platform for proteomics and metabolomics.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Not applicable.

References

  1. Farag, M.A.; Sallam, I.E.; Fekry, M.I.; Zaghloul, S.S.; El-Dine, R.S. Metabolite profiling of three Opuntia ficus-indica fruit cultivars using UPLC-QTOF-MS in relation to their antioxidant potential. Food Biosci. 2020, 36, 100673. [Google Scholar] [CrossRef]
  2. Salehi, E.; Emam-Djomeh, Z.; Askari, G.; Fathi, M. Opuntia ficus indica fruit gum: Extraction, characterization, antioxidant activity and functional properties. Carbohydr. Polym. 2019, 206, 565–572. [Google Scholar] [CrossRef]
  3. Bouyahya, A.; Belmehdi, O.; Benjouad, A.; Ameziane El Hassani, R.; Amzazi, S.; Dakka, N.; Bakri, Y. Pharmacological properties and mechanism insights of Moroccan anticancer medicinal plants: What are the next steps? Ind. Crops Prod. 2020, 147, 112198. [Google Scholar] [CrossRef]
  4. Abd El-Moaty, H.I.; Sorour, W.A.; Youssef, A.K.; Gouda, H.M. Structural elucidation of phenolic compounds isolated from Opuntia littoralis and their antidiabetic, antimicrobial and cytotoxic activity. South Afr. J. Bot. 2020, 131, 320–327. [Google Scholar] [CrossRef]
  5. Kim, J.W.; Kim, T.B.; Kim, H.W.; Park, S.W.; Kim, H.P.; Sung, S.H. Hepatoprotective Flavonoids in Opuntia ficus-indica Fruits by Reducing Oxidative Stress in Primary Rat Hepatocytes. Pharm. Mag 2017, 13, 472–476. [Google Scholar] [CrossRef] [Green Version]
  6. Kumar, D.; Kumar, R.; Ramajayam, R.; Lee Keun, W.; Shin, D.-S. Synthesis, Antioxidant and Molecular Docking Studies of (-)-Catechin Derivatives. J. Korean Chem. Soc. 2021, 65, 106–112. [Google Scholar] [CrossRef]
  7. Albano, C.; Negro, C.; Tommasi, N.; Gerardi, C.; Mita, G.; Miceli, A.; De Bellis, L.; Blando, F. Betalains, Phenols and Antioxidant Capacity in Cactus Pear [Opuntia ficus-indica (L.) Mill.] Fruits from Apulia (South Italy) Genotypes. Antioxidants 2015, 4, 269–280. [Google Scholar] [CrossRef]
  8. Chauhan, S.P.; Sheth, N.R.; Rathod, I.S.; Suhagia, B.N.; Maradia, R.B. Analysis of betalains from fruits of Opuntia species. Phytochem. Rev. 2013, 12, 35–45. [Google Scholar] [CrossRef]
  9. Selma, M.V.; Espín, J.C.; Tomás-Barberán, F.A. Interaction between Phenolics and Gut Microbiota: Role in Human Health. J. Agric. Food Chem. 2009, 57, 6485–6501. [Google Scholar] [CrossRef]
  10. Thursby, E.; Juge, N. Introduction to the human gut microbiota. Biochem J. 2017, 474, 1823–1836. [Google Scholar] [CrossRef]
  11. Aura, A.-M. Microbial metabolism of dietary phenolic compounds in the colon. Phytochem. Rev. 2008, 7, 407–429. [Google Scholar] [CrossRef]
  12. Jiménez, N.; Esteban-Torres, M.; Mancheño, J.M.; de Las Rivas, B.; Muñoz, R. Tannin degradation by a novel tannase enzyme present in some Lactobacillus plantarum strains. Appl Environ. Microbiol 2014, 80, 2991–2997. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Jimenez-Diaz, L.; Caballero, A.; Segura, A. Pathways for the Degradation of Fatty Acids in Bacteria. In Aerobic Utilization of Hydrocarbons, Oils and Lipids; Handbook of Hydrocarbon and Lipid Microbiology; Springer: Cham, Switzerland, 2017; pp. 1–23. [Google Scholar]
  14. López de Felipe, F.; de Las Rivas, B.; Muñoz, R. Bioactive compounds produced by gut microbial tannase: Implications for colorectal cancer development. Front. Microbiol 2014, 5, 684. [Google Scholar] [CrossRef] [PubMed]
  15. Modrackova, N.; Vlkova, E.; Tejnecky, V.; Schwab, C.; Neuzil-Bunesova, V. Bifidobacterium β-Glucosidase Activity and Fermentation of Dietary Plant Glucosides Is Species and Strain Specific. Microorganisms 2020, 8, 839. [Google Scholar] [CrossRef] [PubMed]
  16. Schoefer, L.; Mohan, R.; Schwiertz, A.; Braune, A.; Blaut, M. Anaerobic degradation of flavonoids by Clostridium orbiscindens. Appl Environ. Microbiol 2003, 69, 5849–5854. [Google Scholar] [CrossRef] [Green Version]
  17. Zheng, S.; Geng, D.; Liu, S.; Wang, Q.; Liu, S.; Wang, R. A newly isolated human intestinal bacterium strain capable of deglycosylating flavone C-glycosides and its functional properties. Microb. Cell Factories 2019, 18, 1–10. [Google Scholar] [CrossRef] [Green Version]
  18. Rowland, I.; Gibson, G.; Heinken, A.; Scott, K.; Swann, J.; Thiele, I.; Tuohy, K. Gut microbiota functions: Metabolism of nutrients and other food components. Eur. J. Nutr. 2018, 57, 1–24. [Google Scholar] [CrossRef] [Green Version]
  19. Farag, M.A.; Abdelwareth, A.; Sallam, I.E.; el Shorbagi, M.; Jehmlich, N.; Fritz-Wallace, K.; Serena Schäpe, S.; Rolle-Kampczyk, U.; Ehrlich, A.; Wessjohann, L.A.; et al. Metabolomics reveals impact of seven functional foods on metabolic pathways in a gut microbiota model. J. Adv. Res. 2020, 23, 47–59. [Google Scholar] [CrossRef]
  20. Uhlig, S.; Negård, M.; Heldal, K.K.; Straumfors, A.; Madsø, L.; Bakke, B.; Eduard, W. Profiling of 3-hydroxy fatty acids as environmental markers of endotoxin using liquid chromatography coupled to tandem mass spectrometry. J. Chromatogr. A 2016, 1434, 119–126. [Google Scholar] [CrossRef]
  21. Sun, L.; Chen, L.; Jiang, Y.; Zhao, Y.; Wang, F.; Zheng, X.; Li, C.; Zhou, X. Metabolomic profiling of ovary in mice treated with FSH using ultra performance liquid chromatography/mass spectrometry. Biosci Rep. 2018, 38, BSR20180965. [Google Scholar] [CrossRef]
  22. Das, M.; Saeid, A.; Hossain, M.F.; Jiang, G.-H.; Eun, J.B.; Ahmed, M. Influence of extraction parameters and stability of betacyanins extracted from red amaranth during storage. J. Food Sci Technol 2019, 56, 643–653. [Google Scholar] [CrossRef] [PubMed]
  23. Zin, M.; Bánvölgyi, S. Conventional extraction of betalain compounds from beetroot peels with aqueous ethanol solvent. Acta Aliment. 2020, 49, 163–169. [Google Scholar] [CrossRef]
  24. Lazăr, S.; Constantin, O.E.; Stănciuc, N.; Aprodu, I.; Croitoru, C.; Râpeanu, G. Optimization of Betalain Pigments Extraction Using Beetroot by-Products as a Valuable Source. Inventions 2021, 6, 50. [Google Scholar] [CrossRef]
  25. Zupanets, I.A.; Pidpruzhnykov, Y.V.; Sabko, V.E.; Bezugla, N.P.; Shebeko, S.K. UPLC-MS/MS quantification of quercetin in plasma and urine following parenteral administration. Clin. Phytoscience 2019, 5, 1–12. [Google Scholar] [CrossRef]
  26. Jang, G.H.; Kim, H.W.; Lee, M.K.; Jeong, S.Y.; Bak, A.R.; Lee, D.J.; Kim, J.B. Characterization and quantification of flavonoid glycosides in the Prunus genus by UPLC-DAD-QTOF/MS. Saudi J. Biol. Sci. 2018, 25, 1622–1631. [Google Scholar] [CrossRef]
  27. Lee, S.-H.; Kim, H.-W.; Lee, M.-K.; Kim, Y.J.; Asamenew, G.; Cha, Y.-S.; Kim, J.-B. Phenolic profiling and quantitative determination of common sage (Salvia plebeia R. Br.) by UPLC-DAD-QTOF/MS. Eur. Food Res. Technol. 2018, 244, 1637–1646. [Google Scholar] [CrossRef] [Green Version]
  28. Byun, D.-H.; Choi, H.-J.; Lee, H.-W.; Jeon, H.-Y.; Choung, W.-J.; Shim, J.-H. Properties and applications of β-glycosidase from Bacteroides thetaiotaomicron that specifically hydrolyses isoflavone glycosides. Int. J. Food Sci. Technol. 2015, 50, 1405–1412. [Google Scholar] [CrossRef]
  29. Szymanowska-Powałowska, D.; Orczyk, D.; Leja, K. Biotechnological potential of Clostridium butyricum bacteria. Braz J Microbiol 2014, 45, 892–901. [Google Scholar] [CrossRef] [Green Version]
  30. Chang, F.; Zhang, X.; Pan, Y.; Lu, Y.; Fang, W.; Fang, Z.; Xiao, Y. Light induced expression of β-glucosidase in Escherichia coli with autolysis of cell. BMC Biotechnol. 2017, 17, 1–11. [Google Scholar] [CrossRef] [Green Version]
  31. Gouripur, G.; Kaliwal, B. Screening and optimization of β-glucosidase producing newly isolated Lactobacillus plantarum strain LSP-24 from colostrum milk. Biocatal. Agric. Biotechnol. 2017, 11, 89–96. [Google Scholar] [CrossRef]
  32. Farag, M.A.; Sharaf El-Din, M.G.; Aboul-Fotouh Selim, M.; Owis, A.I.; Abouzid, S.F. Mass spectrometry-based metabolites profiling of nutrients and anti-nutrients in major legume sprouts. Food Biosci. 2021, 39, 100800. [Google Scholar] [CrossRef]
  33. Nemeth, K.; Piskula, M.K. Food Content, Processing, Absorption and Metabolism of Onion Flavonoids. Crit. Rev. Food Sci. Nutr. 2007, 47, 397–409. [Google Scholar] [CrossRef] [PubMed]
  34. Lee, H.C.; Jenner, A.M.; Low, C.S.; Lee, Y.K. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res. Microbiol. 2006, 157, 876–884. [Google Scholar] [CrossRef] [PubMed]
  35. Mecocci, P.; Polidori, M.C. Antioxidant clinical trials in mild cognitive impairment and Alzheimer’s disease. Biochim. Et Biophys. Acta (BBA)—Mol. Basis Dis. 2012, 1822, 631–638. [Google Scholar] [CrossRef] [PubMed]
  36. Kumar, P.; Yuvakkumar, R.; Vijayakumar, S.; Vaseeharan, B. Cytotoxicity of phloroglucinol engineered silver (Ag) nanoparticles against MCF-7 breast cancer cell lines. Mater. Chem. Phys. 2018, 220, 402–408. [Google Scholar] [CrossRef]
  37. Wan, J.-X.; Lim, G.; Lee, J.; Sun, X.-B.; Gao, D.-Y.; Si, Y.-X.; Shi, X.-L.; Qian, G.-Y.; Wang, Q.; Park, Y.-D. Inhibitory effect of phloroglucinol on α-glucosidase: Kinetics and molecular dynamics simulation integration study. Int. J. Biol. Macromol. 2019, 124, 771–779. [Google Scholar] [CrossRef]
  38. Cha, B.K.; Choi, C.H.; Kim, B.J.; Oh, H.-C.; Kim, J.W.; Do, J.H.; Kim, J.G.; Chang, S.K. The Effect of Phloroglucinol in Diarrhea-Dominant Irritable Bowel Syndrome: Randomized, Double-Blind, Placebo-Controlled Trial. Gastroenterology 2011, 140, S-611–S-612. [Google Scholar] [CrossRef]
  39. Fernández-Fernández, R.; López-Martínez, J.C.; Romero-González, R.; Martínez-Vidal, J.L.; Alarcón Flores, M.I.; Garrido Frenich, A. Simple LC–MS Determination of Citric and Malic Acids in Fruits and Vegetables. Chromatographia 2010, 72, 55–62. [Google Scholar] [CrossRef]
  40. Al Kadhi, O.; Melchini, A.; Mithen, R.; Saha, S. Development of a LC-MS/MS Method for the Simultaneous Detection of Tricarboxylic Acid Cycle Intermediates in a Range of Biological Matrices. J. Anal. Methods Chem. 2017, 2017, 5391832. [Google Scholar] [CrossRef] [Green Version]
  41. Huang, Y.; Sun, H.-Y.; Qin, X.-L.; Li, Y.-J.; Liao, S.-G.; Gong, Z.-P.; Lu, Y.; Wang, Y.-L.; Wang, A.-M.; Lan, Y.-Y.; et al. A UPLC-MS/MS Method for Simultaneous Determination of Free and Total Forms of a Phenolic Acid and Two Flavonoids in Rat Plasma and Its Application to Comparative Pharmacokinetic Studies of Polygonum capitatum Extract in Rats. Molecules 2017, 22, 353. [Google Scholar] [CrossRef]
  42. Zhu, L.-W.; Li, X.-H.; Zhang, L.; Li, H.-M.; Liu, J.-H.; Yuan, Z.-P.; Chen, T.; Tang, Y.-J. Activation of glyoxylate pathway without the activation of its related gene in succinate-producing engineered Escherichia coli. Metab. Eng. 2013, 20, 9–19. [Google Scholar] [CrossRef] [PubMed]
  43. Burow, L.C.; Mabbett, A.N.; Blackall, L.L. Anaerobic glyoxylate cycle activity during simultaneous utilization of glycogen and acetate in uncultured Accumulibacter enriched in enhanced biological phosphorus removal communities. ISME J. 2008, 2, 1040–1051. [Google Scholar] [CrossRef] [PubMed]
  44. Parthasarathy, A.; Cross, P.J.; Dobson, R.C.J.; Adams, L.E.; Savka, M.A.; Hudson, A.O. A Three-Ring Circus: Metabolism of the Three Proteogenic Aromatic Amino Acids and Their Role in the Health of Plants and Animals. Front. Mol. Biosci. 2018, 5, 29. [Google Scholar] [CrossRef] [PubMed]
  45. Figueroa-Pérez, M.G.; Pérez-Ramírez, I.F.; Paredes-López, O.; Mondragón-Jacobo, C.; Reynoso-Camacho, R. Phytochemical Composition and in Vitro Analysis of Nopal (O. Ficus-Indica) Cladodes at Different Stages of Maturity. Int. J. Food Prop. 2018, 21, 1728–1742. [Google Scholar] [CrossRef] [Green Version]
  46. Alavi, S.; Sharif, A. Antioxidant activity of gallic acid as affected by an extra carboxyl group than pyrogallol in various oxidative environments: Antioxidant activity of gallic acid and pyrogallol. Eur. J. Lipid Sci. Technol. 2018, 120, 1800319. [Google Scholar] [CrossRef]
  47. Lima, V.N.; Oliveira-Tintino, C.D.M.; Santos, E.S.; Morais, L.P.; Tintino, S.R.; Freitas, T.S.; Geraldo, Y.S.; Pereira, R.L.S.; Cruz, R.P.; Menezes, I.R.A.; et al. Antimicrobial and enhancement of the antibiotic activity by phenolic compounds: Gallic acid, caffeic acid and pyrogallol. Microb. Pathog. 2016, 99, 56–61. [Google Scholar] [CrossRef]
  48. Pérez-Navarro, J.; Da Ros, A.; Masuero, D.; Izquierdo-Cañas, P.M.; Hermosín-Gutiérrez, I.; Gómez-Alonso, S.; Mattivi, F.; Vrhovsek, U. LC-MS/MS analysis of free fatty acid composition and other lipids in skins and seeds of Vitis vinifera grape cultivars. Food Res. Int. 2019, 125, 108556. [Google Scholar] [CrossRef]
  49. Yip, L.Y.; Basri, N.; Lim, K.L.; Tan, G.S.; Tan, D.S.W.; Lim, T.K.H.; Ho, Y.S. Targeted LC/MS-Based Quantitative Determination of 8 Endogenous Free Fatty Acids in Human Pleural Effusion Using Surrogate Analytes. FASEB J. 2017, 31, lb229. [Google Scholar] [CrossRef]
  50. Feng, W.; Ao, H.; Peng, C. Gut Microbiota, Short-Chain Fatty Acids, and Herbal Medicines. Front. Pharm. 2018, 9, 1354. [Google Scholar] [CrossRef]
  51. McDonald, J.A.K.; Mullish, B.H.; Pechlivanis, A.; Liu, Z.; Brignardello, J.; Kao, D.; Holmes, E.; Li, J.V.; Clarke, T.B.; Thursz, M.R.; et al. Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota. Gastroenterology 2018, 155, 1495–1507.e1415. [Google Scholar] [CrossRef]
  52. Luu, M.; Visekruna, A. Short-chain fatty acids: Bacterial messengers modulating the immunometabolism of T cells. Eur. J. Immunol. 2019, 49, 842–848. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Yang, S.; Sadilek, M.; Synovec, R.E.; Lidstrom, M.E. Liquid chromatography–tandem quadrupole mass spectrometry and comprehensive two-dimensional gas chromatography–time-of-flight mass spectrometry measurement of targeted metabolites of Methylobacterium extorquens AM1 grown on two different carbon sources. J. Chromatogr. A 2009, 1216, 3280–3289. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Li, Y.; Tang, W.; Chen, J.; Jia, R.; Ma, L.; Wang, S.; Wang, J.; Shen, X.; Chu, Z.; Zhu, C.; et al. Development of Marker-Free Transgenic Potato Tubers Enriched in Caffeoylquinic Acids and Flavonols. J. Agric. Food Chem. 2016, 64, 2932–2940. [Google Scholar] [CrossRef] [PubMed]
  55. Cabañas-García, E.; Areche, C.; Jáuregui-Rincón, J.; Cruz-Sosa, F.; Pérez-Molphe Balch, E. Phytochemical Profiling of Coryphantha macromeris (Cactaceae) Growing in Greenhouse Conditions Using Ultra-High-Performance Liquid Chromatography–Tandem Mass Spectrometry. Molecules 2019, 24, 705. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Yisimayili, Z.; Abdulla, R.; Tian, Q.; Wang, Y.; Chen, M.; Sun, Z.; Li, Z.; Liu, F.; Aisa, H.A.; Huang, C. A comprehensive study of pomegranate flowers polyphenols and metabolites in rat biological samples by high-performance liquid chromatography quadrupole time-of-flight mass spectrometry. J. Chromatogr. A 2019, 1604, 460472. [Google Scholar] [CrossRef]
  57. Missaoui, M.; D’Antuono, I.; D’Imperio, M.; Linsalata, V.; Boukhchina, S.; Logrieco, A.F.; Cardinali, A. Characterization of Micronutrients, Bioaccessibility and Antioxidant Activity of Prickly Pear Cladodes as Functional Ingredient. Molecules 2020, 25, 2176. [Google Scholar] [CrossRef]
  58. Sallam, I.E.; Abdelwareth, A.; Attia, H.; Aziz, R.K.; Homsi, M.N.; von Bergen, M.; Farag, M.A. Effect of Gut Microbiota Biotransformation on Dietary Tannins and Human Health Implications. Microorganisms 2021, 9, 965. [Google Scholar] [CrossRef]
  59. Ramirez, C.E.; Nouzova, M.; Benigni, P.; Quirke, J.M.E.; Noriega, F.G.; Fernandez-Lima, F. Fast, ultra-trace detection of juvenile hormone III from mosquitoes using mass spectrometry. Talanta 2016, 159, 371–378. [Google Scholar] [CrossRef] [Green Version]
  60. Parada Venegas, D.; De la Fuente, M.K.; Landskron, G.; González, M.J.; Quera, R.; Dijkstra, G.; Harmsen, H.J.M.; Faber, K.N.; Hermoso, M.A. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Front. Immunol. 2019, 10, 277. [Google Scholar] [CrossRef] [Green Version]
  61. Lawhon, S.; Maurer, R.; Suyemoto, M.; Altier, C. Intestinal short-chain fatty acids alter Salmonella Typhimurium invasion gene expression and virulence through BarA/SirA. Mol. Microbiol. 2003, 46, 1451–1464. [Google Scholar] [CrossRef]
  62. Ge, H.; Li, X.; Weiszmann, J.; Wang, P.; Baribault, H.; Chen, J.-L.; Tian, H.; Li, Y. Activation of G Protein-Coupled Receptor 43 in Adipocytes Leads to Inhibition of Lipolysis and Suppression of Plasma Free Fatty Acids. Endocrinology 2008, 149, 4519–4526. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Munné-Bosch, S.; Pintó-Marijuan, M. Free Radicals, Oxidative Stress and Antioxidants. In Encyclopedia of Applied Plant Sciences, 2nd ed.; Thomas, B., Murray, B.G., Murphy, D.J., Eds.; Academic Press: Oxford, UK, 2017; pp. 16–19. [Google Scholar]
  64. Becker, N.; Kunath, J.; Loh, G.; Blaut, M. Human intestinal microbiota: Characterization of a simplified and stable gnotobiotic rat model. Gut Microbes 2011, 2, 25–33. [Google Scholar] [CrossRef] [PubMed]
  65. Javdan, B.; Lopez, J.G.; Chankhamjon, P.; Lee, Y.-C.J.; Hull, R.; Wu, Q.; Wang, X.; Chatterjee, S.; Donia, M.S. Personalized Mapping of Drug Metabolism by the Human Gut Microbiome. Cell 2020, 181, 1661–1679.e1622. [Google Scholar] [CrossRef]
  66. De Leo, M.; Abreu, M.B.D.; Pawlowska, A.M.; Cioni, P.L.; Braca, A. Profiling the chemical content of Opuntia ficus-indica flowers by HPLC–PDA-ESI-MS and GC/EIMS analyses. Phytochem. Lett. 2010, 3, 48–52. [Google Scholar] [CrossRef]
  67. Guevara-Figueroa, T.; Jiménez-Islas, H.; Reyes-Escogido, M.L.; Mortensen, A.G.; Laursen, B.B.; Lin, L.-W.; De León-Rodríguez, A.; Fomsgaard, I.S.; Barba de la Rosa, A.P. Proximate composition, phenolic acids, and flavonoids characterization of commercial and wild nopal (Opuntia spp.). J. Food Compos. Anal. 2010, 23, 525–532. [Google Scholar] [CrossRef]
  68. Mata, A.; Ferreira, J.P.; Semedo, C.; Serra, T.; Duarte, C.M.M.; Bronze, M.R. Contribution to the characterization of Opuntia spp. juices by LC–DAD–ESI-MS/MS. Food Chem. 2016, 210, 558–565. [Google Scholar] [CrossRef] [PubMed]
  69. Salem, M.A.; Perez de Souza, L.; Serag, A.; Fernie, A.R.; Farag, M.A.; Ezzat, S.M.; Alseekh, S. Metabolomics in the Context of Plant Natural Products Research: From Sample Preparation to Metabolite Analysis. Metabolites 2020, 10, 37. [Google Scholar] [CrossRef] [Green Version]
  70. Benzie, I.F.F.; Strain, J.J. The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay. Anal. Biochem. 1996, 239, 70–76. [Google Scholar] [CrossRef] [Green Version]
  71. Liang, Z.; Cheng, L.; Zhong, G.-Y.; Liu, R.H. Antioxidant and Antiproliferative Activities of Twenty-Four Vitis vinifera Grapes. PLoS ONE 2014, 9, e105146. [Google Scholar] [CrossRef]
  72. Zhang, H.; Hassan, Y.I.; Liu, R.; Mats, L.; Yang, C.; Liu, C.; Tsao, R. Molecular Mechanisms Underlying the Absorption of Aglycone and Glycosidic Flavonoids in a Caco-2 BBe1 Cell Model. ACS Omega 2020, 5, 10782–10793. [Google Scholar] [CrossRef]
Molecules 27 07568 g001 550
Figure 1. Chemical structures of detected metabolites from UHPLC-QTOF-MS analysis of O. ficus assayed in vitro and ex vivo with gut microbiota, * indicates biotransformed metabolites.
Figure 1. Chemical structures of detected metabolites from UHPLC-QTOF-MS analysis of O. ficus assayed in vitro and ex vivo with gut microbiota, * indicates biotransformed metabolites.
Molecules 27 07568 g001
Molecules 27 07568 g002 550
Figure 2. Bar chart showing changes in metabolite classes relative percentile levels set to 100% in O. ficus samples (A) treated in vitro at two time intervals, 0.5 and 24 h, with gut microbiota and (B) ex vivo untreated vs. treated samples with human fecal bacterial culture.
Figure 2. Bar chart showing changes in metabolite classes relative percentile levels set to 100% in O. ficus samples (A) treated in vitro at two time intervals, 0.5 and 24 h, with gut microbiota and (B) ex vivo untreated vs. treated samples with human fecal bacterial culture.
Molecules 27 07568 g002
Molecules 27 07568 g003 550
Figure 3. Proposed biotransformation pathways of flavonoids (red and blue) and gallic acid derivatives (green) in O. opuntia, (number) peak number of metabolites; green in in vitro assay and red in ex-vivo assay as presented in Table 1 and Supplementary Table S2.
Figure 3. Proposed biotransformation pathways of flavonoids (red and blue) and gallic acid derivatives (green) in O. opuntia, (number) peak number of metabolites; green in in vitro assay and red in ex-vivo assay as presented in Table 1 and Supplementary Table S2.
Molecules 27 07568 g003
Molecules 27 07568 g004 550
Figure 4. Proposed biotransformation pathways of fatty and organic acid mediated by the glyoxylate pathway, (number) peak number of metabolites; green in in vitro assay and red in ex vivo assay as present in Table 1 and Supplementary Table S2.
Figure 4. Proposed biotransformation pathways of fatty and organic acid mediated by the glyoxylate pathway, (number) peak number of metabolites; green in in vitro assay and red in ex vivo assay as present in Table 1 and Supplementary Table S2.
Molecules 27 07568 g004
Molecules 27 07568 g005 550
Figure 5. (A) OPLS model of O. ficus in vitro treated with gut microbiota based on incubation time; 24 h treatment samples (blue) modeled against 0.5 h (green). (B) S-plot of OPLS model, where metabolites with negative p values showed an increased abundance with 0.5 treatment samples, mainly malic and citric acid.
Figure 5. (A) OPLS model of O. ficus in vitro treated with gut microbiota based on incubation time; 24 h treatment samples (blue) modeled against 0.5 h (green). (B) S-plot of OPLS model, where metabolites with negative p values showed an increased abundance with 0.5 treatment samples, mainly malic and citric acid.
Molecules 27 07568 g005
Molecules 27 07568 g006 550
Figure 6. Schematic representation of the proposed (A) in vitro and (B) ex vivo protocol to assess the impact of gut microbiota on O. ficus metabolites.
Figure 6. Schematic representation of the proposed (A) in vitro and (B) ex vivo protocol to assess the impact of gut microbiota on O. ficus metabolites.
Molecules 27 07568 g006
Table
Table 1. Metabolites identified using high-resolution UHPLC-QTOF-MS in O. ficus samples treated with gut microbiota at two time intervals, 0.5 and 24 h, along with their relative abundance.
Table 1. Metabolites identified using high-resolution UHPLC-QTOF-MS in O. ficus samples treated with gut microbiota at two time intervals, 0.5 and 24 h, along with their relative abundance.
Peak No.[M-H]−Rt (sec)Molecular FormulaError (ppm)MS/MSNameClassO. ficus Treated with Gut Microbiota (0.5 h) *O. ficus Treated with Gut Microbiota (24 h) *
1133.016066C4H6O5−9.08115, 71.01Malic acidOrganic acid+−
2169.015879C7H6O5−11.61125.02, 107.01, 97.03, 79.02Gallic acidPhenolic acid+++
3191.022281C6H8O7−9.04173.03, 129.01, 111, 99, 83.01(iso)citric acidOrganic acid+−
4207.0159112C6H8O8−5.73191.05, 127, 115, 99, 87, 73.03Hydroxycitric acidOrganic acid+++
5125.0256139C6H6O3−9.21107.01, 97.02, 79.02PyrogallolPhenolics−+
6117.0205164C4H6O4−9.9499.01, 73.03Succinic acidOrganic acid+++
7125.0256171C6H6O3−9.66107.01, 91.08, 79.01PhloroglucinolPhenolics−+
8205.0368174C7H10O7−7.28191.05, 127, 111.01Homocitric acidOrganic acid+−
9153.0214339C7H6O4−15.21109.02, 93.03, 82Protocatechuic acidPhenolic acid+−
10199.0265356C8H8O6−10.21101.38Fumarylacetoacetic acid (Maleylacetoacetic acid)Organic acid+++
11117.0566383C5H10O3−5.1599.02Hydroxypentanoic acid (hydroxyvaleric acid)SCFA+++
12541.2307471C26H38O120.92315.13Isorhamnetin glycosideFlavonoids+++
13219.0532509C8H12O7−8.11191.05, 127, 111.01, 87.01Dimethyl citrateOrganic acid+++
14183.032553C8H8O5−11.75168, 124.01, 97.02, 78.01Methyl gallatePhenolic acid+++
15165.0578589C9H10O3−15.19147.04,
119.05, 91.01		3-(4-Hydroxyphenyl) propanoic acidPhenolic acid−+
16285.043644C15H10O6−9.12268.03, 243.03, 195.04, 169.06, 151.03KaempferolFlavonoids−+
17563.1102691C25H24O15−10.56447.09, 301.03, 151Quercetin glycosideFlavonoids+++
18349.0618713C9H18O142.8197.04, 169.01, 125.05Ethyl gallate derivativePhenolic acid+−
19301.0387788C15H10O7−10.4179.07, 151QuercetinFlavonoids+++
20271.0627803C15H12O5−5.18253.15, 209.36, 177.37, 151.01, 119.04NaringeninFlavonoids+−
21287.2249835C16H32O4−8.02271.02, 243.05, 133.01, 115Dihydroxyhexadecanoic acidFatty acids+++
22443.1753844C17H32O132.99329.23, 133.01, 71.01Trihydroxyoctadecenoic acid derivativeFatty acids+++
23329.2358860C18H34O5−7.33133.01, 71.01Trihydroxyoctadecenoic acidFatty acids−+
24663.2948874C41H44O85.15547.28, 431.26, 287.23, 133.01, 115Dihydroxyhexadecanoic acid derivativeFatty acids+−
25547.2805888C26H44O12−8.15519.26, 431.26, 287.22, 143.03, 133.01, 115Dihydroxyhexadecanoic acid derivativeFatty acids+++
26269.0478893C15H10O5−6.99251.16, 225.04, 201.06, 151, 117.03ApigeninFlavonoids+++
27299.0577902C16H12O6−11.77284.03, 248.08, 151DiosmetinFlavonoids+−
28283.0643921C16H12O5−9.88268.04, 239.03, 211.04, 179.03, 151.01, 117.03AcacetinFlavonoids+−
29277.1822997C17H26O3−4.53253.18, 223.06, 123PanaxytriolFatty alcohol−+
30483.31611028C23H48O100.82379.08, 321.39, 255.23, 237.05Palmitic acid derivativeFatty acids+−
31239.07011033C15H12O36.99207.04, 197.36, 135.03HydroxyflavanoneFlavonoids+−
32295.23011039C18H32O3−7.16277.21, 251, 183.13Hydroxylinoleic acidFatty acids+−
33243.19841066C14H28O3−6.11219.01, 171.27, 99.02Hydroxytetradecanoic acidFatty acids+−
34271.22781132C16H32O3−0.76253.19, 225.22Hydroxyhexadecanoic acidFatty acids+++
35471.35091132C30H48O4−6.39429.35, 359.09, 306.09Hydroxybetulinic acidTriterpenoid+−
36253.21961192C16H30O2−8.38235.23, 209.15Palmitoleic acidFatty acids+−
37279.23511222C18H32O2−7.06237.09, 187.01Linoleic acidFatty acids+−
38255.23551247C16H32O2−10.98237.25, 183.1Palmitic acidFatty acids+++
39281.25211258C18H34O2−10.85237.03, 171.1Oleic acidFatty acids+−
* ++, +, −; reflects the metabolite relative abundance as depicted from the peak abundance data extracted from MS-DIAL, (++) increased abundance, (+) present, (−) absent.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Sallam, I.E.; Rolle-Kampczyk, U.; Schäpe, S.S.; Zaghloul, S.S.; El-Dine, R.S.; Shao, P.; Bergen, M.v.; Farag, M.A. Evaluation of Antioxidant Activity and Biotransformation of Opuntia Ficus Fruit: The Effect of In Vitro and Ex Vivo Gut Microbiota Metabolism. Molecules 2022, 27, 7568. https://doi.org/10.3390/molecules27217568

AMA Style

Sallam IE, Rolle-Kampczyk U, Schäpe SS, Zaghloul SS, El-Dine RS, Shao P, Bergen Mv, Farag MA. Evaluation of Antioxidant Activity and Biotransformation of Opuntia Ficus Fruit: The Effect of In Vitro and Ex Vivo Gut Microbiota Metabolism. Molecules. 2022; 27(21):7568. https://doi.org/10.3390/molecules27217568

Chicago/Turabian Style

Sallam, Ibrahim E., Ulrike Rolle-Kampczyk, Stephanie Serena Schäpe, Soumaya S. Zaghloul, Riham S. El-Dine, Ping Shao, Martin von Bergen, and Mohamed A. Farag. 2022. "Evaluation of Antioxidant Activity and Biotransformation of Opuntia Ficus Fruit: The Effect of In Vitro and Ex Vivo Gut Microbiota Metabolism" Molecules 27, no. 21: 7568. https://doi.org/10.3390/molecules27217568

Article Metrics

Back to TopTop